Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
11/2003
11/06/2003CA2481449A1 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003CA2481285A1 Non nucleoside reverse transcriptase inhibitors
11/05/2003EP1358309A1 Composition and method for bleachin g a substrate
11/05/2003EP1358237A1 (cyclo)condensation of isocyanate compounds
11/05/2003EP1358165A1 Imidazole derivatives
11/05/2003EP1358144A1 Epothilone synthesis components iii and iv: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone b, d and epothilone derivatives
11/05/2003EP1357905A2 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
11/05/2003EP1153006B1 Stabilised compositions of o- and n-vinyl compounds and the use of ammonium salts as stabilisers
11/05/2003EP1066246B1 Novel cationic couplers and their use for oxidation dyeing
11/05/2003CN1454086A High affinity small molecule C5A receptor modulators
11/04/2003US6642379 Containing oxazolyl, thiazolyl or imidazolyl groups
11/04/2003US6642258 Use of central cannabinoid receptor antagonist for preparing medicines
11/04/2003US6642218 (5Z,7E,22E)-(1S,3R,24R)-25-(5-Propyloxazol-2-yl)-26,27-cyclo -9,10-secocholesta-5,7,10(19), 22-tetraene-1,3,24-triol for treatment of diseases characterized by hyperproliferation and deficient cell differentiation
11/04/2003CA2272483C Pyrazoles
11/04/2003CA2094773C 2,4-dioxoimidazolidine derivatives
10/2003
10/30/2003WO2003088917A2 Regulation of tnf-alpha
10/30/2003WO2003088915A2 Novel sodium channel blockers
10/30/2003WO2003088908A2 Heterocyclo inhibitors of potassium channel function
10/30/2003WO2003088903A2 Compounds, compositions, and methods
10/30/2003WO2003066579A3 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
10/30/2003WO2002069901A3 Cathepsin cysteine protease inhibitors
10/30/2003WO2002066425A3 Compositions and methods for hydration of terminal alkynes
10/30/2003WO2002064136A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/30/2003US20030204086 Novel heterocyclic amide derivatives
10/30/2003US20030204041 Ionic liquids
10/30/2003US20030203943 A chemical complex of niacinamide and H2 histamine receptor antagonist which is selected from ranitidine, cimetidine, famotidine, nizatidine and derivatives; a medicament or a dietary- supplement for immunomodulation in a mammal
10/30/2003US20030203915 Compounds that are nitrosated and/or nitrosylated through one or more sites such as oxygen (hydroxyl condensation), sulfur (sulfhydryl condensation) and/or nitrogen
10/30/2003US20030203913 Beta3 adrenergic receptor agonists and uses thereof
10/30/2003CA2482035A1 Novel sodium channel blockers
10/29/2003EP1357134A2 Catalyst compositions for the polymerization of olefins
10/29/2003EP1357124A1 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1089964B1 Hydrazine derivatives
10/29/2003EP1012166B1 1-amino-7-isoquinoline derivatives as serine protease inhibitors
10/29/2003CN1125816C Method for removing nitrous acid gas
10/28/2003US6639105 For inhibiting tumor cell growth
10/28/2003US6639076 Such as 2-(2-amino-2-methylpropanoylamino)-n-(1-(2-oxo-1-phenyl-2-pyrrolidinylethyl -4-yl)-4-phenylbutanamide
10/28/2003US6638980 Inhibitors of factor Xa
10/28/2003US6638967 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine
10/28/2003US6638962 Cycloheptene compounds
10/28/2003US6638944 Have urea containing substituent at 1-position; induce biosynthesis of cytokines such as interferon and tumor necrosis factor, exhibit antiviral and antitumor properties
10/28/2003US6638927 Melanocortin-4 receptor (MC4-R) agonists; treating obesity or diabetes; 4-((N-cyclohexyl-3,5-dimethyl-piperazine-1-carboximidoyl)-amino)-N-(2-(2,4 -dichlorophenyl) -ethyl)-benzamide for example
10/28/2003US6638321 Oxidation color dyes for hair from aniline compounds
10/28/2003CA2104268C Preparation of imidazoles
10/28/2003CA2101179C Phenylimidazolidine derivatives, their preparation and their use
10/23/2003WO2003087127A2 Antimicrobial compounds against staphylococci, mycobacteria, and other infectious agents
10/23/2003WO2003087111A1 Method for the production of monohydro-perfluoroalkanes, bis(perfluoroalkyl)phosphinates, and perfluoroalkylphosphonates
10/23/2003WO2003087110A1 Method for the production of bis(perfluoroalkyl)phosphinic acids and the salts thereof
10/23/2003WO2003087063A1 Imidazolidine compounds as chemokine receptor modulators
10/23/2003WO2003087045A1 Novel methoxybenzamide compounds for use in mch receptor related disorders
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003087036A1 Stereoselective process for the synthesis of (d)-2-amino-5-phenylpentanoic or alkyl ester thereof
10/23/2003WO2003086605A2 Functionalized ionic liquids, and methods of use thereof
10/23/2003WO2003086390A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003086282A2 Nitric oxide donors, compositions and methods of use
10/23/2003WO2002092056A8 Compaction process for manufacture of sodium phenytoin dosage form
10/23/2003WO2002081483A3 Inhibitors of acyl glucosaminyl inositol amidase and methods of use
10/23/2003US20030199701 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative
10/23/2003US20030199700 Preparation method of 2,2'-bi-1H-imidazole using glyoxal and an ammonium salt
10/23/2003US20030199566 Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same
10/23/2003US20030199565 Gastrin and cholecystokinin receptor ligands(II)
10/23/2003US20030199563 Heterocyclic containing biphenyl aP2 inhibitors and method
10/23/2003US20030199560 Bisaryl compound and medicament for cancer treatment comprising the same
10/23/2003US20030199550 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/23/2003US20030199522 Such as (2S)-(-)-2-(2-aminoethoxy)-3-(1-phenyl-1H-imidazol-4-yl)propanoic acid for treating thrombosis, atherosclerosis, adhesions, scarring, cancer, fibrosis, inflammation, and conditions which benefit from maintaining brandykinin levels
10/23/2003US20030199521 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection
10/23/2003US20030199499 Novel guanidinobenzamides
10/23/2003CA2482656A1 Method for the production of bis(perfluoroalkyl)phosphinic acids and the salts thereof
10/23/2003CA2482341A1 Novel methoxybenzamide compounds for use in mch receptor related disorders
10/23/2003CA2481532A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003CA2481202A1 Functionalized ionic liquids, and methods of use thereof
10/23/2003CA2480856A1 Substituted aryl amides
10/23/2003CA2480832A1 Nitric oxide donors, compositions and methods of use
10/22/2003EP1353924A1 Synthesis of temozolomide and analogs
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1353895A2 Primary intermediates for oxidative coloration of hair
10/22/2003EP1353692A2 Methods and compositions for treatment of ocular neovascularization and neural injury
10/22/2003EP1353669A1 Method for treating glaucoma ib
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1353638A1 Novel couplers for use in oxidative hair dyeing
10/22/2003EP1353637A1 Novel couplers for use in oxidative hair dyeing
10/22/2003EP1353636A1 Novel couplers for use in oxidative hair dyeing
10/22/2003EP1066022B1 Compositions for oxidation dyeing keratin fibres comprising a cationic coupler, novel cationic couplers, their use for oxidation dyeing and dyeing methods
10/22/2003EP0881218B1 Preventives/remedies for complications of diabetes
10/22/2003CN1450999A Novel piperazine derivatives
10/22/2003CN1450991A Hydroxamate derives useful as deacetylase inhibitors
10/22/2003CN1125144C Azo comounds and process for producing the same
10/22/2003CN1125054C Novel imidazolidine derivatives, their preparation their use and pharmaceutical preparations comprising them
10/22/2003CN1125023C Substance for inducing cell death
10/22/2003CN1124841C Cosmetic skin lightening product for topical application
10/21/2003US6635761 Catalyst and method for trimerization of isocyanates
10/21/2003US6635630 Respiratory system disorders; antiinflammatory agents
10/21/2003US6635417 Complex formation between DSDNA and oligomer of cyclic heterocycles
10/21/2003CA2273989C New histidine derivatives, preparation process, and their use as free antiradical agents
10/21/2003CA2240136C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
10/16/2003WO2003084934A1 Novel crystal form of 5-hydroxy-1-methylhydantoin
10/16/2003WO2003084933A2 Method for the production of chiral imidazolidin-2-ones
10/16/2003WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same
10/16/2003WO2003084916A2 Compounds that modulate ppar activity and methods for their preparation
10/16/2003WO2003062171A3 Method for the separation of acids from chemical reaction mixtures by means of ionic fluids
1 ... 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 ... 345